Crossmark

ASC nanobodies to counteract the consequences of inflammasome activation

Published Online: 2022-05-16

Published Print: 2022-06-08

Authors

Adriouch, Sahil https://orcid.org/0000-0002-0265-7773
Pelegrin, Pablo https://orcid.org/0000-0002-9688-1804
Funding

Funding for this research was provided by:

Ministerio de Ciencia e Innovación (PID2020‐116709RB‐I00)

Fundación Séneca (20859/PI/18)

MEC | Instituto de Salud Carlos III (DTS21/00080)

EC | Horizon 2020 Framework Programme (965196)
License Information

Text and Data Mining valid from 2022-05-16

Version of Record valid from 2022-05-16
More Information

Article History

Received: 25 April 2022

Revised: 3 May 2022

Accepted: 3 May 2022

First Online: 16 May 2022

Document is current